Sugi Predict

Sugi Predict / Compounds / Dexamethasone

Dexamethasone

Dexamethasone

SCHEMBL3135309

C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO.C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2C(=O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

NR3C1

The experimentally established mechanism targets of Dexamethasone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 known ✓ P04150 9/20 0.68
▸ CYP3A4 P08684 7/20 0.68
▸ HSD17B10 Q99714 7/20 0.68
▸ HIF1A Q16665 7/20 0.68
▸ TSHR P16473 3/20 0.68
▸ NFKB1 P19838 3/20 0.68
▸ PGR P06401 3/20 0.68
▸ PMP22 Q01453 3/20 0.68
▸ AR P10275 2/20 0.68
▸ CYP2D6 P10635 2/20 0.68
▸ MEN1 O00255 1/20 0.68
▸ KMT2A Q03164 1/20 0.68
▸ APEX1 P27695 1/20 0.68
▸ NPSR1 Q6W5P4 1/20 0.68
▸ IKBKB O14920 1/20 0.68
▸ CHUK O15111 1/20 0.68
▸ ADRB2 P07550 1/20 0.68
▸ NR3C2 P08235 1/20 0.68
▸ PLA2G2A P14555 1/20 0.68
▸ NFKB2 Q00653 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Betamethasone SCHEMBL3224067 1.00 NR3C1 (0.68) NR3C1CYP3A4HSD17B10HIF1ATSHR
Cortisone SCHEMBL14862166 0.92 HSD17B10 (0.69) NR3C1CYP3A4HSD17B10HIF1ATSHR
Dexamethasone SCHEMBL1408949 0.91 NR3C1 (0.72) NR3C1CYP3A4HSD17B10HIF1ATSHR
Betamethasone SCHEMBL13724083 0.91 NR3C1 (0.72) NR3C1CYP3A4HSD17B10HIF1ATSHR
Dexamethasone SCHEMBL322760 0.89 HIF1A (0.69) NR3C1CYP3A4HSD17B10HIF1ATSHR
Dexamethasone SCHEMBL4743981 0.86 HSD17B10 (0.65) NR3C1CYP3A4HSD17B10HIF1ATSHR
Betamethasone SCHEMBL28086533 0.86 HIF1A (0.66) NR3C1CYP3A4HSD17B10HIF1ATSHR
Triamcinolone SCHEMBL3043158 0.86 HSD17B10 (0.71) NR3C1CYP3A4HSD17B10HIF1ATSHR
Betamethasone SCHEMBL21808820 0.85 NR3C1 (0.76) NR3C1CYP3A4HSD17B10HIF1ATSHR
Dexamethasone SCHEMBL4085868 0.85 NR3C1 (0.76) NR3C1CYP3A4HSD17B10HIF1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117017998-A Cannabidiol for lowering steroid doses and treating inflammatory and autoimmune diseases 斯特罗生物技术公司 2023-11-10 — — CN disclosed
EP-3452046-A1 CANNABIDIOL FOR REDUCING A STEROID DOSE AND TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES Stero Biotechs Ltd. (IL) 2019-03-13 — — EP disclosed
CN-109414443-A Cannabidiol for reducing steroid doses and treating inflammatory and autoimmune diseases 斯特罗生物技术公司 2019-03-01 — — CN disclosed
WO-2017191630-A1 CANNABIDIOL FOR REDUCING A STEROID DOSE AND TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES STERO BIOTECHS LTD. (IL) 2017-11-09 — — WO disclosed
US-8425943-B2 Method of treatment using solubilized protein composition obtained from eggshell membrane BIOVA, L.L.C. (US) 2013-04-23 — — US disclosed
US-20120237495-A1 METHOD OF TREATMENT USING SOLUBILIZED PROTEIN COMPOSITION OBTAINED FROM EGGSHELL MEMBRANE BIOVA, L.L.C. (US) 2012-09-20 — — US disclosed
US-8211477-B2 Solubilized protein composition obtained from eggshell membrane BIOVA, L.L.C. (US) 2012-07-03 — — US disclosed
US-20100029564-A1 NOVEL PROCESS OF SOLUBILIZING PROTEIN FROM A PROTEINACEOUS MATERIAL AND COMPOSITIONS THEREOF BIOVA, L.L.C. (US) 2010-02-04 — — US disclosed
US-20050171192-A1 Use of histamine to treat bone disease MAXIM PHARMACEUTICALS, INC. 2005-08-04 — — US disclosed
WO-2005060960-A2 USE OF HISTAMINE TO TREAT BONE DISEASE MAXIM PHARMACEUTICALS, INC. (US) 2005-07-07 — — WO disclosed
Send feedback